Let’s talk about multifunctional excipients! 💊 Canada, contact Janie Chalifoux-Leblond Martyn Brown or email us at customercare@rettenmaier.ca
Learn more about PROSOLV® SMCC, a high-functionality, multifunctional excipient that simplifies processing, delivers superior inherent properties, and boosts drug formulation performance. Click the Link Below to Learn More and Request a Sample! https://lnkd.in/eGjeB-sp #JRSPharma #PROSOLVSMCC #Excipients
Learn more about PROSOLV® SMCC, a high-functionality, multifunctional excipient that simplifies processing, delivers superior inherent properties, and boosts drug formulation performance. Click the Link Below to Learn More and Request a Sample! https://lnkd.in/eGjeB-sp #JRSPharma #PROSOLVSMCC #Excipients
Discover more about PROSOLV® SMCC a high-functionality, multifunctional excipient that simplifies processing, offering superior inherent properties, and enhances the performance of the drug formulation. Click the Link Below to Learn More and Request a Sample! https://lnkd.in/eGjeB-sp #JRSPharma #PROSOLVSMCC #Excipients
Time is running out! Only a few days left to register for our exclusive webinar on POLYOX™ Polyethylene Oxide. Timing is everything—secure your spot now to access valuable insights and strategies that can transform your drug formulation processes. Learn how POLYOX™ is versatile across complex and unique applications, and can revolutionize your approach. Don’t miss this opportunity to learn from the best! Don’t Miss Out – Sign Up Here! https://lnkd.in/gACrxghC #LastChance #RegisterNow #PharmaWebinar #ExclusiveContent #PharmaInsights
We often get asked, "Can we predict laboratory CU testing by using BU data generated from NIR spectra of the blend in a tablet press feed frame?" We often say in response, "That potentially carries a larger NIR calibration burden and may be a hard place to start. However, the NIR spectra used to generate BU data may provide valuable information for CU sampling and for an initial material diversion strategy, even without RTRt". The recently published and below referenced paper by Alexander Ryckaert, Matthew Cannon et al provides some great insight into this area.
Monitoring blend uniformity with PAT tools like NIR during #ContinuousManufacturing is standard in pharma. However, the current diversion approaches often reject compliant tablets. In collaboration with Matthew Cannon from GSK, and prof. Thomas De Beer, in this article by Ryckaert et al. we propose a more efficient method to reduce yield loss by diverting only non-compliant tablets. This URL offers 50 days of free access. Read and share with others interested. https://lnkd.in/getT95th
💡 Liquid vs. Lyophilized: Which is right for your drug? Liquid formulations are simple and cost-effective, while lyophilized options ensure stability for sensitive molecules. Let us guide you in making the best choice by offering expertise in both formats and tailored manufacturing solutions. Get in touch with Kari Roberts to find out more about our liquid and lyo CDMO services! #CDMO #DrugDevelopment #Lyophilization #BTLLCSolutions
🌟 Let’s explore this fantastic paper: The promising role of #semi-solid extrusion technology in custom drug formulation for #pediatricmedicine 👥 By Roseline Mazet et al. ✨ Read it here #OpenAccess: https://lnkd.in/gXhZcuZb
Transform your drug formulation process with unparalleled efficiency! 💊🧪 ⚡ Screen 800+ excipients in just 24 hours with precision. 💊🔬 💻 Fail fast with digital simulations to avoid costly setbacks. 🧬📉 📊 Test stability across 50+ formulations in a single day. 🧪💡 Stay tuned for more updates—Coming Soon! 📢 #DrugFormulation #PharmaceuticalInnovation #ExcipientScreening #DigitalSimulations #StabilityTesting #FormulationEfficiency #PharmaTech #ResearchAndDevelopment #FailFast #ComingSoon #DrugDevelopment #pharmadem #formulation
Monitoring blend uniformity with PAT tools like NIR during #ContinuousManufacturing is standard in pharma. However, the current diversion approaches often reject compliant tablets. In collaboration with Matthew Cannon from GSK, and prof. Thomas De Beer, in this article by Ryckaert et al. we propose a more efficient method to reduce yield loss by diverting only non-compliant tablets. This URL offers 50 days of free access. Read and share with others interested. https://lnkd.in/getT95th
New PharmaEng publication proposes an approach to support continuous manufacturing decision-making towards a more efficient manufacturing process.
Monitoring blend uniformity with PAT tools like NIR during #ContinuousManufacturing is standard in pharma. However, the current diversion approaches often reject compliant tablets. In collaboration with Matthew Cannon from GSK, and prof. Thomas De Beer, in this article by Ryckaert et al. we propose a more efficient method to reduce yield loss by diverting only non-compliant tablets. This URL offers 50 days of free access. Read and share with others interested. https://lnkd.in/getT95th
Sometimes you get lucky. Your drug product morphology is ideal for manufacturing. It dissolves at the perfect rate and is very stable for long periods in extreme environments. Most of us don't get that lucky. But a skilled CDMO can help you anticipate and overcome many of these challenges with advanced formulation techniques: https://hubs.la/Q030kNq30 #CorealisPharma #CDMO #SolidScience #DrugDevelopment #PharmaInnovation
